Bavarian Nordic — Oktober 2020
-
Test
-
Ses vi kl. 17? https://event.webinarjam.com/register/8/rp8nvfw
-
Sanofi Q3 2020: "Third-quarter Soliqua
/Suliqua
sales increased 27.3% to €40 million driven by launches in Rest of the World. In the first nine months, Soliqua
sales increased 41.0% supported by strong growth in all three regions."Ak ja, Zealand Pharma havde fat i et godt produkt.
-
Absolut uenig! Produktet var måske godt nok, men det tog alt for lang tid inden Sanofi kom op i omdrejninger, og oveni så kom der jo som bekendt også nye og bedre produkter på markedet i en lind strøm og overhalede kombiprodukternes berettigelse?!
-
Prøv i øvrigt lige at regne på Zealands marginale afkast på "sølle" 40. mio. euro, hold op imod en pæn mia kr. ved frasalget - ingen tvivl om, hvad jeg som investor ville vælge?! Vh.
-
Selvfølgelig

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind